Resectable pancreatic adenocarcinoma Clinical Trials

Delta Trials records 1 clinical trial for Resectable pancreatic adenocarcinoma in its publicly accessible dataset. From the full dataset, 1 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 297 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.